SpineJournal.gr

–Anticipates Full Year 2009 Revenue of Approximately $370 Million
–Announces Full Year 2010 Revenue Guidance of $480 Million to $500 Million
SAN DIEGO, Jan 29, 2010 /PRNewswire via COMTEX/ — NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, today announced preliminary unaudited financial results for the full year ended December 31, 2009. More »

SAN DIEGO, Oct. 20 /PRNewswire-FirstCall/ – NuVasive, Inc. (Nasdaq: NUVA – News), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today financial results for the quarter ended September 30, 2009. More »